BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6230438)

  • 1. Intestinal absorption and metabolism of clioquinol in the rat.
    Kotaki H; Yamamura Y; Tanimura Y; Saitoh Y; Nakagawa F; Tamura Z
    J Pharmacobiodyn; 1983 Nov; 6(11):881-7. PubMed ID: 6230438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enterohepatic circulation of clioquinol in the rat.
    Kotaki H; Yamamura Y; Tanimura Y; Saitoh Y; Nakagawa F; Tamura Z
    J Pharmacobiodyn; 1984 Jun; 7(6):420-5. PubMed ID: 6237189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absorption, distribution and metabolism of clioquinol in clioquinol-sensitive and -resistant neonatal rats.
    Kotaki H; Hori S; Saitoh Y; Nakagawa F; Tamura Z
    J Pharmacobiodyn; 1986 Dec; 9(12):970-4. PubMed ID: 2952786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex difference of the metabolic disposition of clioquinol in rats.
    Ohshima N; Kotaki H; Saitoh Y; Nakagawa F; Tamura Z
    J Pharmacobiodyn; 1989 Jul; 12(7):371-7. PubMed ID: 2531797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of 14C-iodochlorhydroxyquin in the dog and the rat.
    Jurima M; Kalow W; Inaba T
    J Pharmacobiodyn; 1984 Mar; 7(3):164-70. PubMed ID: 6235361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased absorption of iodochlorhydroxyquin by rat intestine in the presence of solubilizing agents.
    Kasai M; Kanamitsu M; Katada T; Tokumitsu Y; Itaya K; Ui M
    Toxicology; 1977 Dec; 8(3):327-32. PubMed ID: 145669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absorption of 8-hydroxyquinolines through the human skin.
    Fischer T; Fagerlund C; Hartvig P
    Acta Derm Venereol; 1978; 58(5):407-11. PubMed ID: 82350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Appearance of intoxication in rats by intraperitoneal administration of clioquinol.
    Kotaki H; Nakajima K; Tanimura Y; Saitoh Y; Nakagawa F; Tamura Z; Nagashima K
    J Pharmacobiodyn; 1983 Oct; 6(10):773-83. PubMed ID: 6229623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous absorption of iodochlorhydroxyquin in humans.
    Stohs SJ; Ezzedeen FW; Anderson AK; Baldwin JN; Makoid MC
    J Invest Dermatol; 1984 Feb; 82(2):195-8. PubMed ID: 6229586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Various factors affecting intestinal absorption of iodochlorhydroxyquin in rat and man.
    Hayashi M; Fuwa T; Awazu S; Hanano M
    Chem Pharm Bull (Tokyo); 1976 Nov; 24(11):2603-9. PubMed ID: 138487
    [No Abstract]   [Full Text] [Related]  

  • 11. Differences in species of iodochlorhydroxyquin absorption, metabolism, and excretion.
    Hayashi M; Fuwa T; Awazu S; Hanano M
    Chem Pharm Bull (Tokyo); 1976 Nov; 24(11):2589-96. PubMed ID: 138486
    [No Abstract]   [Full Text] [Related]  

  • 12. Percutaneous absorption of clioquinol (Vioform).
    Degen PH; Moppert J; Schmid K; Weirich EG
    Dermatologica; 1979; 159(4):295-301. PubMed ID: 157893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal absorption of oestrone, oestrone glucuronide and oestrone sulphate in the rat in situ--I. Importance of hydrolytic enzymes on conjugate absorption.
    Sim SM; Back DJ
    J Steroid Biochem; 1985 Jun; 22(6):781-8. PubMed ID: 4021481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous absorption and disposition of iodochlorhydroxyquin in dogs.
    Ezzedeen FW; Stohs SJ; Kilzer KL; Makoid MC; Ezzedeen NW
    J Pharm Sci; 1984 Oct; 73(10):1369-72. PubMed ID: 6239025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous absorption of iodochlorhydroxyquin in humans and dogs.
    Stohs SJ; Ezzedeen FW
    Pediatrics; 1984 Jun; 73(6):880-1. PubMed ID: 6233531
    [No Abstract]   [Full Text] [Related]  

  • 16. Absorption of iodochlorhydroxyquin in humans.
    Wilcock M
    J Invest Dermatol; 1985 Jan; 84(1):79. PubMed ID: 3155546
    [No Abstract]   [Full Text] [Related]  

  • 17. [Appearance of intoxication, and plasma and tissue clioquinol concentrations after intravenous administration of clioquinol to rabbits].
    Kotaki H; Nakajima K; Tanimura Y; Saitoh Y; Nakagawa F; Nagashima K; TamuraZ
    Yakugaku Zasshi; 1984 Apr; 104(4):413-7. PubMed ID: 6238155
    [No Abstract]   [Full Text] [Related]  

  • 18. Changes in lipid peroxide concentrations in plasma and tissues by repeated administration of clioquinol to neonatal rats.
    Ohshima N; Kotaki H; Hori S; Saitoh Y; Nakagawa F; Tamura Z
    J Pharmacobiodyn; 1988 Jun; 11(6):424-9. PubMed ID: 2971795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal absorption and excretion of aflatoxin in rats.
    Kumagai S
    Toxicol Appl Pharmacol; 1989 Jan; 97(1):88-97. PubMed ID: 2492684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of potential causes for the incomplete bioavailability of furosemide: gastric first-pass metabolism.
    Lee MG; Chiou WL
    J Pharmacokinet Biopharm; 1983 Dec; 11(6):623-40. PubMed ID: 6678312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.